DE69033181D1 - Iga-rezeptorspezifische monoklonale antikörper - Google Patents

Iga-rezeptorspezifische monoklonale antikörper

Info

Publication number
DE69033181D1
DE69033181D1 DE69033181T DE69033181T DE69033181D1 DE 69033181 D1 DE69033181 D1 DE 69033181D1 DE 69033181 T DE69033181 T DE 69033181T DE 69033181 T DE69033181 T DE 69033181T DE 69033181 D1 DE69033181 D1 DE 69033181D1
Authority
DE
Germany
Prior art keywords
monoclonal antibodies
specific monoclonal
iga receptor
iga
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69033181T
Other languages
English (en)
Other versions
DE69033181T2 (de
Inventor
Li Shen
Michael Fanger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dartmouth College
Original Assignee
Dartmouth College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dartmouth College filed Critical Dartmouth College
Application granted granted Critical
Publication of DE69033181D1 publication Critical patent/DE69033181D1/de
Publication of DE69033181T2 publication Critical patent/DE69033181T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coating With Molten Metal (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
DE69033181T 1989-10-20 1990-10-19 Iga-rezeptorspezifische monoklonale antikörper Expired - Fee Related DE69033181T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42488389A 1989-10-20 1989-10-20
PCT/US1990/006030 WO1991005805A1 (en) 1989-10-20 1990-10-19 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR

Publications (2)

Publication Number Publication Date
DE69033181D1 true DE69033181D1 (de) 1999-07-29
DE69033181T2 DE69033181T2 (de) 1999-10-21

Family

ID=23684271

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69033181T Expired - Fee Related DE69033181T2 (de) 1989-10-20 1990-10-19 Iga-rezeptorspezifische monoklonale antikörper

Country Status (9)

Country Link
US (1) US5610057A (de)
EP (1) EP0496818B1 (de)
JP (1) JPH05504677A (de)
AT (1) ATE181558T1 (de)
CA (1) CA2067244C (de)
DE (1) DE69033181T2 (de)
DK (1) DK0496818T3 (de)
ES (1) ES2132072T3 (de)
WO (1) WO1991005805A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018031A (en) * 1989-10-20 2000-01-25 Trustees Of Dartmouth College Binding agents specific for IgA receptor
US5582996A (en) * 1990-12-04 1996-12-10 The Wistar Institute Of Anatomy & Biology Bifunctional antibodies and method of preparing same
US5846782A (en) 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US5559099A (en) * 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
US6465253B1 (en) 1994-09-08 2002-10-15 Genvec, Inc. Vectors and methods for gene transfer to cells
US6111166A (en) * 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
US5770442A (en) 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
JPH11507057A (ja) * 1995-06-07 1999-06-22 メダレツクス・インコーポレーテツド 抗アレルギー性二特異性分子
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US5922845A (en) * 1996-07-11 1999-07-13 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
US20030017138A1 (en) 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
US6929946B1 (en) 1998-11-20 2005-08-16 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
CN1268645C (zh) * 1999-07-30 2006-08-09 米德列斯公司 含有抗－fc受体结合剂的治疗化合物
US20010051147A1 (en) * 2000-03-27 2001-12-13 Van De Winkel Jan G.J. Methods for immunostimulation using binding agents for the Fc receptor of immunoglobulin A
US7235233B2 (en) 2000-09-26 2007-06-26 Crucell Holland B.V. Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
KR100890088B1 (ko) 2001-02-12 2009-03-24 메다렉스, 인코포레이티드 Ｆｃ 알파 수용체（ＣＤ８９）에 대한 인간 모노클로날 항체
ES2335657T3 (es) 2002-04-25 2010-03-31 Crucell Holland B.V. Medios y metodos para la produccion de vectores de adenovirus.
US20060165675A1 (en) * 2002-08-02 2006-07-27 Richman-Eisenstat Janice Beth Modulation of mesenchymal cells via iga-receptors
CA2585849A1 (en) * 2004-10-29 2006-05-11 Elusys Therapeutics, Inc. Use of cr1-binding molecules in clearance and induction of immune responses
EP2127666A1 (de) * 2008-05-28 2009-12-02 Drug Discovery Factory B.V. Verfahren zur Behandlung oder Prophylaxe von chronischen Entzündungskrankheiten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4676980A (en) * 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4954617A (en) * 1986-07-07 1990-09-04 Trustees Of Dartmouth College Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes

Also Published As

Publication number Publication date
ES2132072T3 (es) 1999-08-16
DE69033181T2 (de) 1999-10-21
WO1991005805A1 (en) 1991-05-02
EP0496818B1 (de) 1999-06-23
EP0496818A1 (de) 1992-08-05
JPH05504677A (ja) 1993-07-22
CA2067244C (en) 2000-12-19
US5610057A (en) 1997-03-11
ATE181558T1 (de) 1999-07-15
DK0496818T3 (da) 1999-11-22
CA2067244A1 (en) 1991-04-21

Similar Documents

Publication Publication Date Title
DE69033181D1 (de) Iga-rezeptorspezifische monoklonale antikörper
DE69032979D1 (de) Bispezifische heteroantikörper mit zweifachen effektorfunktionen
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
DK180380A (da) Hybrid cellelinie og fremgangsmaade til fremstilling og anvendelse deraf
AU8083594A (en) Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
PT817847E (pt) Receptor de il-17
CA2220461A1 (en) Therapeutic compounds comprised of anti-fc receptor antibodies
IL61863A (en) Monoclonal antibody to a human monocyte antigen,its production and diagnostic and pharmaceutical compositions contaiing it
AU7488187A (en) Fc receptor for immunoglobulin
ES2187946T3 (es) Uso de interleucina-15.
ATE427488T1 (de) Monoklonaler antikírper fur die inhibierung von hiv-1-hullgykoprotein-vermittelte membranfusion
AU3376297A (en) Human thyrotropin receptor compositions and use thereof
ATE233788T1 (de) Interleukin-15-rezeptoren
NO970740L (no) Glutamat reseptor
NO802751L (no) Hybrid cellelinje for fremstilling av monoclonalt antistoff til cytotoksiske og suppressor t-celler hos mennesker, samt fremgangsmaate til fremstilling av antistoffet
WO1995024481A3 (en) Humanized monoclonal antibodies against human interleukin-4
WO1999046379A3 (en) Human receptor proteins; related reagents and methods
WO1997020045A3 (en) P2u2 purinergic receptor
EP0396505A3 (de) Für einen Immunoglobulin-Isotyp spezifische monoklonale Antikörper
DK0952853T3 (da) Konjugat omfattende et aktivt middel, et polypeptid og en polyether
ATE361980T1 (de) Polypeptid-fragmente die fähig sind mit dem antigen i/ii von streptococcus mutans zu konkurrieren
AU5809390A (en) Monoclonal antibodies directed against activated microglial cells, hybridomas secreting these monoclonal antibodies, antigen recognized by these monoclonal antibodies and their applications
ATE207935T1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
NO20020329L (no) Antitumor-antistoffer, proteiner og anvendelse derav
FI974018A (fi) Ihmisen 2 integriini -alayksikkö

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee